In this article, the management of cutaneous T-cell lymphoma will be presented in terms of the strategies that guide treatment. With the strategies and goals in mind, treatment options to achieve a measurable goal will be presented. The treatments presented in this article are those utilized to reliably achieve a remission. If remission is not achieved, a patient’s management plan must be changed. The landmarks that help guide the therapy plan will be discussed.
Latkowski JA, Heald P.
Contact Us
Xstrahl to Attend VCS and ASDS Conferences in Orlando: The recent hurricanes have affected so many, and the team at Xstrahl hopes that you and your family are safe. Our hearts go out to everyone as they face this difficult time ahead. Prior to the hurricanes, Xstrahl committed to attending two conferences in Orlando, FL this week, and organizers of the conferences have confirmed that they will still be happening. If you are attending either conference in Orlando, please visit our team to say hello. We’d love to meet you.
Xstrahl presented The role of radiation technologists as a radiotherapy treatment at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 2024 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in Washington, DC Sept. 29-Oct 2, 2024, at booth #1937.
